Amphetamine, migraine, and brain noradrenergic activation: contradictions in headache research.
Gupta
Vinod K
VK
D001921:Brain / Q000503:physiopathology*; D001923:Brain Chemistry / Q000187:drug effects; D002110:Caffeine / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D000075202:Contraindications; D018592:Cross-Over Studies; D003913:Dextroamphetamine / Q000627:therapeutic use; D006801:Humans; D008881:Migraine Disorders / Q000503:physiopathology* / Q000517:prevention & control*; D009638:Norepinephrine / Q000502:physiology*; D010865:Pilot Projects; D018781:Tension-Type Headache / Q000517:prevention & control*
D000697:Central Nervous System Stimulants; D002110:Caffeine; D003913:Dextroamphetamine; D009638:Norepinephrine